RAINBOW Rainbow Childrens Medicare Q2 FY26 results (Jul–Sep 2025) and concall
Rainbow Children's Medicare reported a soft Q2 FY26, primarily due to a lower-than-expected incidence of seasonal illnesses and an early festive season which compressed peak admission periods. Despite the transient impact on occupancy and PAT, the company continues its aggressive expansion, having integrated new acquisitions in Guwahati and Warangal. Management remains confident in long-term growth, backed by a strong project pipeline and a transition to a professional leadership structure with the appointment of a new Group CEO.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 6.7%, net profit down 3.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 417 | 398 | 370 | 353 | 445 +7% |
| EBITDA | 147 | 134 | 115 | 104 | 149 +1% |
| Net profit | 79 | 69 | 57 | 54 | 76 −4% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
